A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

Clinical trial NCT06533059 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06533059
Sponsor: Alterome Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Breast Cancer Endometrial Cancer Metastatic Cancer Advanced Solid Tumor

Start date: 2024-08-22
Primary completion: 2026-12-29
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.